Experimental Parkinson’s therapy may have robust weight-loss effect
University of Florida News, Filed under Health, Research on Tuesday, March 24, 2009
A growth factor used in clinical experiments to rescue dying brain cells in Parkinson patients may cause unwanted weight loss if delivered to specific areas of the brain, according to University of Florida researchers in the March online edition of Molecular Therapy.
States Consider Harder Line on Stem Cell Research
Fox News, By James Osborne, Tuesday, March 24, 2009
Legislators in Georgia and Oklahoma are considering bills that would limit, if not outright prohibit, scientists from working with human embryonic stem cells in their research to cure or reverse medical conditions, including diabetes, paralysis and Parkinson’s disease. In Texas and Mississippi, lawmakers are considering blocking state funding for that research, mirroring existing laws in other states.
EPA Calls CO2 a Danger — At Last
Time, By Bryan Walsh, Monday, Mar. 23, 2009
It’s been two years since the U.N. Intergovernmental Panel on Climate Change laid out the definitive case that human beings were causing global warming, and two decades since NASA scientist James Hansen first told Congress of the threat of rising CO2 emissions. So, why has it taken this long for the Environmental Protection Agency (EPA) to announce that greenhouse gases endanger human health? Change can be slow in Washington.
One Man’s Rules for Parkinson’s
The Washington Post, Tuesday, March 24, 2009; Page HE04
After I took speech therapy, my therapist recommended that I put up signs everywhere, saying THINK LOUD. I did as I was told.
More Than $2 Million From New York State To Fund Stem Cell Research At Rensselaer
Medical News Today, Article Date: 24 Mar 2009 – 2:00 PDT
Two groups of Rensselaer researchers each have received a $1.08 million grant from New York through the state’s stem cell research initiative. Both grants will fund research on the growth and development of stem cells and will provide some of the first insights available into the role specific genes and biological molecules play in stem cell function in the human body.
Human Adult Testes Cells Can Become Embryonic-like
ScienceDaily (Mar. 24, 2009)
Using what they say is a relatively simple method, scientists at Georgetown University Medical Center have extracted stem/progenitor cells from adult testes and have converted them back into pluripotent embryonic-like stem cells. Researchers say that the naïve cells are now potentially capable of morphing into any cell type that a body needs, from brain neurons to pancreatic tissue.
Louisiana: State law forbids embryonic stem-cell research, stunting industry
WWLT, Bigad Shaban / Eyewitness News, 11:24 PM CDT on Monday, March 23, 2009
NEW ORLEANS – The moral debate over embryonic stem-cell research is now an issue of economics in Louisiana. President Obama cleared the way for researchers in the field to now receive federal funding, but some scientists say Louisiana will never see the money.
Social Security Administration: Claims move from months to minutes
TGDaily, by Rick C. Hodgi, Monday, March 23, 2009 06:49
Washington (DC) and Armonk (NY) – On Friday, IBM, MedVirginia and the U.S. Social Security Administration (SSA) announced an electronic medical records exchange system to be used in speeding up the process of granting disability benefits “from months to minutes”. The project is part of the $19 billion granted by The American Recovery and Reinvestment Act of 2009.
Hans Keirstead to brief Congress on stem cell research
UCI scientist is behind the field’s first human clinical trial
Today at University of California, Irvine, Calif., March 23, 2009
UC Irvine’s Hans Keirstead – the neurobiologist behind what will be the world’s first human embryonic stem cell clinical trial – will brief Congress on the state of the field 10-11:30 a.m. Tuesday, March 24, in Washington, D.C.
Protein called Shp2 is key to embryonic stem cell differentiation
News-Medical.net, Published: Monday, 23-Mar-2009
Investigators at Burnham Institute for Medical Research (Burnham) have learned that a protein called Shp2 plays a critical role in the pathways that control decisions for differentiation or self-renewal in both human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs).
Can Sound Slow Parkinson’s?
The Med Guru, Published on March 23, 2009
Several small studies have suggested that music therapy can slow the progression of Parkinson’s. One of the best-known clinical trials, from Italy, found that music therapy positively affected movement, emotions and quality of life among a small group of patients.
23andMe already testing for rare Parkinson’s mutations?
Genetic Future, Posted on: March 23, 2009 9:15 AM, by Daniel MacArthur
In other words, the company already has probes on its custom chip targeting these variants, but it isn’t yet reporting results back to customers. Why isn’t it reporting back? If you’d asked me a couple of months ago, I’d say the motivation was probably to avoid the regulatory hassles associated with testing overtly clinical markers…
The Empty Promise of Embryonic Stem Cell Research
Why scientific breakthroughs make the destruction of human embryos obsolete.
ChristianityToday, Rep. Mike Pence | posted 3/23/2009 10:51AM
There is no right more fundamental than the right to life. There is no realm in which more exciting progress has been made than that of science. And the two are not inherently opposed to one another.
Lawmakers eye claims backlog at SSA
GovernmentExecutive. com, By Elizabeth Newell, March 23, 2009
A joint hearing on Tuesday of two House Ways and Means subcommittees will review how the Social Security Administration is addressing the significant backlog of disability benefits claims, and how additional stimulus funding could improve service.
Key Protein May Lead to Faster Acting Anti-Depression Drugs
PR Newswire, March 23, 2009
NEW YORK, March 23 /PRNewswire-USNewswire/ — Research conducted by Nobel laureate Paul Greengard, Medical Director of The Michael Stern Parkinson’s Research Center at The Rockefeller University, Dr. Jennifer L. Warner-Schmidt in New York and colleagues in Sweden, demonstrated in the Journal of Neuroscience that the brain protein called p11 could lead pharmaceutical companies to develop anti-depression drugs that begin working within hours or days rather than the weeks or even months required by current drugs
Drug industry advocates join chorus to split FDA
Associated Press, By MATTHEW PERRONE – 23 March 2009
WASHINGTON (AP) — As momentum builds to rework the nation’s food-safety system after a salmonella outbreak linked to peanuts, the drug industry is hoping for a happy side effect: faster approvals for new medicines.
-
Archives
- March 2009 (176)
- February 2009 (115)
-
Categories
- 18162508
- Anti-Depressant
- Bio Tech Industry
- Caregiver
- Clinical Trials
- Coffee
- Depression
- Documentary
- Electronic Medcial Records
- EMEA
- Environmental Causes
- Ethics
- European Medicines Agency
- FDA
- Generic Drugs
- Genetic Mutation
- Genetics
- Health and Human Services Dept
- Healthcare Reform
- HHS
- IRB
- Law
- Legislation
- Lobbying
- Medical Devices
- Medicare
- Mental Health
- MJ Fox
- Neurotoxins
- NHS (United Kingdom)
- NIH
- NIH Funding
- Obama Administration
- Orphan Drugs
- Other Research
- Parkinson's related video
- PD Cause
- PD Clinical Trials
- PD Medical Clinics
- PD Personal Stories
- PD Prevention Research
- PD Research
- PD Support Group News
- PD Surgery
- PD Therapies
- Pharmaceutical Industry
- Prescription Drugs
- PWP In The News
- Religion
- Research with potential for PD
- Social Security
- Social Web Sites
- Stimulus Package
- Stress Effect
- Uncategorized
- YouTube
-
RSS
Entries RSS
Comments RSS
PWP News 